Use of CD122+ natural killer cell precursors for superior anti-leukemia responses.
S. Guglietta, L. Cardenas, C. Krieg
This study shows that IL-2cx treatment generates and expands NK cells that effectively control AML in vivo without requiring adoptive transfer.
bioRxiv · Oct 24, 2022 · PreprintImmunology